Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 10, 2000, Pages 1011-1014

  Weber, Kevin T ^a   Hammache, Djilali ^b   Fantini, Jacques ^b   Ganem, Bruce ^a  

^a Department of Obstetrics Gynecology   (United States)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN DERIVATIVE; GALACTOSYLCERAMIDE; GLYCOPROTEIN GP 120; N STEARYL 1 DEOXYNOJIRIMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BILAYER MEMBRANE; BINDING AFFINITY; BINDING KINETICS; CONFORMATION; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PARTIAL DRUG SYNTHESIS; STRUCTURE ANALYSIS;

1-DEOXYNOJIRIMYCIN; ANTI-HIV AGENTS; GALACTOSYLCERAMIDES; GLYCOLIPIDS; HIV ENVELOPE PROTEIN GP120; LIPID BILAYERS; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034657518     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00153-0     Document Type: Article

References (27)

1. Ward S.G., Westwick J. Biochem J. 333:1998;457.
2. Cao Y.Z., Friedman-Kien A.E., Huang Y.X., Li X.L., Mirabile M., Moudgil T., Zucker-Franklin D., Ho D.D. J. Virol. 64:1990;2553.
3. Brack-Werner R., Kleinschmidt A., Ludvigsen A., Mellert W., Neumann M., Herrmann R., Khim M.C.L., Burny A., Muller-Lantzsch N., Stavrou D., Erfle V. AIDS. 6:1992;273.
4. Tan X., Pearce-Pratt R., Phillips D.M. J. Virol. 67:1993;6447.
5. Scott-Algara D., Vuillier F., Cayota A., Rame V., Guetard D., Moncany M.L.J., Marasescu M., Dauget C., Dighiero G. J. Gen. Virol. 74:1993;725.
6. Clapham P.R., Weber J.N., Whitby D., McIntosh K., Dalgleish A.G., Maddon P.J., Deen K.C., Sweet R.W., Weiss R.A. Nature. 337:1989;368.
7. Harouse J.M., Bhat S., Spitalnik S.L., Laughlin M., Stefano K., Silberberg D.H., Gonzalez-Scarano F. Science. 253:1991;320.
8. Bhat S., Spitalnik S.L., Gonzalez-Scarano F., Silberberg D.H. Proc. Natl. Acad. Sci. USA. 88:1991;7131.
9. Bertozzi C.R., Cook D.G., Kobertz W.R., Gonzalez-Scarano F., Bednarski M.D. J. Am. Chem. Soc. 114:1992;10639.
10. Long D., Berson J.F., Cook D.G., Doms R.W. J. Virol. 68:1994;5890.
11. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., Gonzalez-Scarano F. Proc. Natl. Acad. Sci. USA. 90:1993;2700.
12. Ruocco M.J., Shipley G.G. Biophys. J. 43:1983;91.
13. Fantini J., Hammache D., Delézay O., Piéroni G., Tamalet C., Yahi N. Virology. 246:1998;211.
14. Pascher I., Sundell S. Chem. Phys. Lipids. 20:1977;175.
15. Skarjune R., Oldfield E. Biochemistry. 21:1982;3154.
16. Hammache D., Piéroni G., Yahi N., Delézay O., Koch N., Lafont H., Tamalet C., Fantini J. J. Biol. Chem. 273:1998;7967.
17. 13C NMR, IR and mass spectrometric data were obtained for all new compounds.
18. Castro B., Dormoy J.-R., Evin G., Selve C. Tetrahedron Lett. 14:1975;1219.
19. Guilbert B., Davis N.J., Flitsch S.L. Tetrahedron Lett. 35:1994;6563.
20. Nicotra F., Ronchetti F., Giovanni R., Toma L. Tetrahedron Lett. 25:1984;5697.
21. Miyake Y., Ebata M. Agric. Biol. Chem. 52:1988;661.
22. Fleet G.W.J., Karpas A., Dwek R.A., Fellows L.E., Tyms A.S., Petursson S., Namgoong S.K., Ramsden N.G., Smith P.W., Chan Son J., Wilson F., Witty D.R., Jacob G.S., Rademacher T.W. FEBS Lett. 237:1988;128.
23. Legler G., Liedtke H. Biol. Chem. Hoppe-Seyler. 366:1985;1113.
24. The interaction between gp120 and the synthetic GalCer analogues was measured with the μ-trough S tensiometer (Kibron Inc., Helsinki, Finland) and the data were analyzed with the FilmWare (version 2.3) software.
25. Lear, J. D.; Rafalski, M. In Viral Fusion Mechanisms; Bentz, J., Ed; CRC: Boca Raton, FL, 1993; pp 55-66.
26. Karpas A., Fleet G.W., Dwek R.A., Petursson S., Namgoong S.K., Ramsden N.G., Jacob G.S., Rademacher T.W. Proc. Natl. Acad. Sci. USA. 85:1988;9229.
27. Karlsson G.B., Butters T.B., Dwek R.A., Platt F.M. J. Biol. Chem. 268:1993;570.